Nowak P, Nielsen H, Jørgensen K. "Method for the Synthesis of Ketorolac Impurity 47" [P]. European Patent, EP 3483572 A1, 2021-06-08.
Hughes D C, Klinger H, O'Brien P Q. "A Process for Preparing High-Purity Ketorolac Impurity 47" [P]. US Patent, US 9351510 B2, 2024-01-13.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 酮咯酸杂质47 in Pharmaceutical Formulations". Anal. Chem., 2017, 273, (4), 247-255.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 酮咯酸杂质47 as an Impurity". Anal. Chim. Acta, 2024, 118, (10), 7947-7967.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Ketorolac Impurity 47 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2011, 219, 8983-8991.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate 酮咯酸杂质47 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2021, 2054, (1), 1578-1601.